More recently, a nonselective TRPV1 antagonist (capsazepine) was found to modulate the peripheral immune response to malaria [25], but no studies have reported to date, a role for TRPV1 in cerebral malaria development and outcome. Here, TRPV1 is linked to cerebral malaria.